| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 61.16 | 2.0% | 458.0% |
| Total Income | 69.78 | 5.3% | 321.9% |
| Expenditure | 73.02 | 37.5% | 289.0% |
| PBT | 178.59 | 1944.8% | 8094.0% |
| Net Profit | 179.82 | 2552.2% | 4177.1% |
| OPM | 100.00% | 87.41pp | 143.56pp |
| NPM | 100.00% | 89.77pp | 126.67pp |
| EPS | 14.08 | 2556.6% | 2773.5% |
Jaykay Enterprises: FY26 PAT Surges to ₹215.65 Cr
27 May 2026 · 27 May, 9:01 pm
Summary
Jaykay Enterprises Ltd. reported exceptionally strong financial performance for Q4 and the full financial year ended March 31, 2026, primarily driven by robust growth across its diversified segments. The company's total income for Q4 FY2025-26 soared by 322% year-on-year to ₹ 69.78 crore, contributing to a full-year total income of ₹ 282.30 crore, an increase of 185% year-on-year. Profit After Tax (PAT) for the full year, significantly boosted by exceptional items related to an investment revaluation, surged to ₹ 215.65 crore. Operationally, the company expanded its Defence & Aerospace capabilities with facility upgrades and new orders, while the Digital Manufacturing & Advanced Systems segment successfully completed its orthopaedic implant project and began commercial deliveries.
Key Highlights
- 1
Jaykay Enterprises Ltd.'s total income for Q4 FY2025-26 surged by 322% year-on-year to ₹ 69.78 crore, compared to ₹ 16.53 crore in Q4 FY2024-25.
- 2
Full-year FY2025-26 total income increased by 185% year-on-year, reaching ₹ 282.30 crore compared to ₹ 98.94 crore in FY2024-25.
- 3
Profit After Tax (PAT) for Q4 FY2025-26 dramatically improved to ₹ 179.82 crore, compared to a loss of ₹ (4.41) crore in the previous year's corresponding quarter.
- 4
The company reported a consolidated Profit After Tax (PAT), including exceptional items, of ₹ 215.65 crore for the full financial year ended March 31, 2026.
- 5
EBIDTA (before exceptional items) grew robustly by 274% year-on-year to ₹ 66.89 crore for FY2025-26, up from ₹ 17.84 crore in the prior year.
- 6
The Defence & Aerospace segment secured significant orders from strategic defence organizations and completed the expansion of its Cherlapally facility, enhancing manufacturing capabilities.
- 7
The Digital Manufacturing & Advanced Systems segment achieved major milestones by completing the Peenya orthopaedic implant project and commencing commercial deliveries of Patient Specific Implants.
Informational and educational content only. Not investment advice.